Literature DB >> 2170378

A novel functional domain of an alpha-like DNA polymerase. The binding site on the herpes simplex virus polymerase for the viral UL42 protein.

P Digard1, D M Coen.   

Abstract

Most DNA-dependent DNA polymerases exist as a complex with one or more noncovalently bound accessory proteins, whose presence is necessary for the correct functioning of the holoenzyme. Using the herpes simplex virus DNA polymerase as a representative member of the alpha-polymerase family, we have recreated the association between the polymerase and its accessory protein UL42 in vitro through the translation in rabbit reticulocyte lysate of bacteriophage RNA polymerase-generated transcripts encoding the two polypeptides. Study of the ability of deleted versions of the polymerase protein to bind UL42, as detected by coimmunoprecipitation of the two polypeptides, defined a carboxyl-terminal region of the DNA polymerase that was both necessary and sufficient for the association. This domain is distinct from regions of the protein previously characterized as involved in catalysis. The results suggest a strategy for the design of novel targeted antiviral drugs, which would disrupt the DNA polymerase-UL42 complex.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2170378

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  Identification of crucial hydrogen-bonding residues for the interaction of herpes simplex virus DNA polymerase subunits via peptide display, mutational, and calorimetric approaches.

Authors:  K G Bridges; C S Chow; D M Coen
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Residues of human cytomegalovirus DNA polymerase catalytic subunit UL54 that are necessary and sufficient for interaction with the accessory protein UL44.

Authors:  Arianna Loregian; Brent A Appleton; James M Hogle; Donald M Coen
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

3.  Evidence against a simple tethering model for enhancement of herpes simplex virus DNA polymerase processivity by accessory protein UL42.

Authors:  Murari Chaudhuri; Deborah S Parris
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

4.  Molecular cloning of the cDNA for the catalytic subunit of human DNA polymerase delta.

Authors:  C L Yang; L S Chang; P Zhang; H Hao; L Zhu; N L Toomey; M Y Lee
Journal:  Nucleic Acids Res       Date:  1992-02-25       Impact factor: 16.971

5.  Cloning, expression, and functional characterization of the equine herpesvirus 1 DNA polymerase and its accessory subunit.

Authors:  Arianna Loregian; Alessandro Case; Enrico Cancellotti; Carlo Valente; Howard S Marsden; Giorgio Palù
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

6.  Inhibition of translation by a short element in the 5' leader of the herpes simplex virus 1 DNA polymerase transcript.

Authors:  Kevin F Bryant; Donald M Coen
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

7.  A 269-amino-acid segment with a pseudo-leucine zipper and a helix-turn-helix motif codes for the sequence-specific DNA-binding domain of herpes simplex virus type 1 origin-binding protein.

Authors:  S Deb; S P Deb
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

8.  Conformational changes induced in herpes simplex virus DNA polymerase upon DNA binding.

Authors:  K Weisshart; A A Kuo; G R Painter; L L Wright; P A Furman; D M Coen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

9.  Herpes simplex ICP27 mutant viruses exhibit reduced expression of specific DNA replication genes.

Authors:  S L Uprichard; D M Knipe
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

10.  Cloning, sequencing, and functional characterization of the two subunits of the pseudorabies virus DNA polymerase holoenzyme: evidence for specificity of interaction.

Authors:  H Berthomme; S J Monahan; D S Parris; B Jacquemont; A L Epstein
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.